臨床研究等提出・公開システム

Date of registration	May. 11, 2022
Last modified on	July. 14, 2022
Trial ID	jRCT1050220024

Scientific Title	Efficacy of embolization for ectopic varix in the afferent portal collateral due to extrahepatic portal vein occlusion
Public Title	Efficacy of embolization for ectopic varix in the afferent portal collateral due to extrahepatic portal vein occlusion

Contact for Scientific Queries	Name	Yamamoto Akira AKIRA
	Affiliation	Osaka Metropolitan University
	Address	1-4-3 Asahimati, Abeno-ku, Osaka, Osaka
	Telephone	+81-6-6645-3831
	E-mail	loveakirayamamoto@gmail.com
Contact for Public Queries	Name	Yamamoto Akira AKIRA
	Affiliation	Osaka City University
	Address	1-4-3 Asahimati, Abeno-ku, Osaka, Osaka
	Telephone	+81-6-6645-3831
	E-mail	loveakirayamamoto@gmail.com

Recruitment status	Recruiting

Anticipated date of first enrollment		May. 11, 2022
Actual date of first enrollment		April. 01, 2022
Target sample size		20
Study Type		Observational
Key inclusion & exclusion criteria	Inclusion Criteria	Patients who underwent embolization treatment for ectopic varices of the hepatorenal portal collateral vessels due to extrahepatic portal vein occlusion at Osaka City University Hospital between September 2012 and December 2020
	Exclusion Criteria	N/A
	Age Minimum	No limit
	Age Maximum	No limit
	Gender	Both
Health Condition(s) or Problem(s) Studied		Obstruction of portal vein
Health Condition(s) Keyword		Portal vein occlusion
Health Condition(s) Code		N/A
Primary Outcome(s)		Blood-free period after initial treatment
Secondary Outcome(s)		Survival after initial treatment

Primary Sponsor	Akira Yamamoto

Name of Certified Review Board	Ethical Committee of Osaka Metropolitan University Graduate School of Medicine
Address	Abeno medics 6F asahimachi, abenoku, Osaka, Osaka
Telephone	+81-6-6645-3457
E-Mail	gr-a-knky-ethics@omu.ac.jp
Approval Status	Approval
Date of approval	Mar. 16, 2022

Plan to share IPD	No

Countries of Recruitment（Except Japan）	none

History of Changes

No	Publication date
2	July. 14, 2022	(this page)	Changes
1	May. 11, 2022	Detail

List of change history